Breaking News

Parker Bioscience Opens Doors to UK Site

Investment includes extended laboratories and new clean room, manufacturing and testing facilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Parker Bioscience Filtration has unveiled brand new, expanded facilities at its Birtley, UK site. This follows the completion of a phased investment program, which included the creation of state-of-the-art office and conferencing spaces, extended laboratories and new clean room, manufacturing and testing facilities.
 
Parker Bioscience Filtration designs, supplies and delivers systems for both upstream and downstream pharmaceutical and biopharmaceutical manufacturing, and provides integrated bioprocessing solutions designed to speed-up development times and increase efficiency and safety to enable reproducible quality.
 
Earlier this year, as part of the same investment program, the company opened a new 600 square meter ISO Class 7 cleanroom facility at the Birtley site. Dedicated to the manufacture of single-use assemblies, it complements the site’s 2400 square meters of existing cleanroom facilities.
 
The investment program has also seen the launch of The SciLog Suite, a facility which will provide Parker Bioscience Filtration’s customers with the opportunity to test and optimize key unit operations within their production process, supporting process development. The SciLog Suite features the company’s automated single-use systems for bioprocessing. These include the SciLog FD for bulk drug filtration and dispense, the SciLog TFF for tangential flow filtration operations and the SciLog NFF for normal flow filtration operations. Able to accommodate more than 20 people, the SciLog Suite provides a resource for personnel working in process development.
 
“It’s hugely exciting to have opened the doors to our extended and refurbished site in Birtley,” said Kris Holmes, general manager, Parker Bioscience Filtration. “The investment in these facilities demonstrates Parker Hannifin’s commitment to our European customer base and through this, we have strengthened the level of technical support and service that we can offer across biopharmaceutical manufacturing. We have shortened the supply chain for our European customers and made it easier for customers to access filtration solutions and automated systems. In addition, we have also provided a greatly enhanced working environment for Parker Bioscience Filtration’s specialist workforce. The overall investment in our laboratory, cleanroom, manufacturing, office and warehouse facilities has made our Birtley premises one of the most modern manufacturing sites for integrated bioprocessing solutions in EMEA.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters